Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011

Eurosurveillance

Volumn 16, Issue 48, 2011, Pages

  Pharris, A ^a   Wiessing, L ^b   Sfetcu, O ^a   Hedrich, D ^b   Botescu, A ^c   Fotiou, A ^d   Nikolopoulos, G K ^e   Malliori, M ^f   Salminen, M ^a   Suk, J E ^a   Griffiths, P ^b   van de Laar, M J ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^c National Observatory on Drugs   (Romania)

^d UNIVERSITY MENTAL HEALTH RESEARCH INSTITUTE   (Greece)

^e Hellenic Centre for Disease Control and Prevention   (Greece)

^f Organisation Against Drugs (OKANA)   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BULGARIA; DISEASE SURVEILLANCE; EUROPE; GREECE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INTRAVENOUS DRUG ABUSE; ITALY; LITHUANIA; LUXEMBOURG; OPIATE SUBSTITUTION TREATMENT; RISK ASSESSMENT; ROMANIA; VIRUS TRANSMISSION;

EID: 83255173840     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC/EMCDDA; Oct 2011. Available from: http://www.ecdc.europa.eu/en/ publications/Publications/111012_Guidance_ECDC-EMCDDA. pdf.
2. Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill. 2011;16(36):pii=19962. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19962
3. Malliori M, Terzidou M, Paraskevis D, Hatzakis A. HIV/AIDS among IDUs in Greece: report of a recent outbreak and initial response policies. [Accessed 29 Nov 2011]. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_143752_EN_HIV_greek_report.pdf
4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Statistical Bulletin 2011. Figure HSR-3. Syringes distributed through specialised programmes per estimated IDU in 2009 or more recent year. Lisbon: EMCDDA; 2011. [Accessed 29 Nov 2011]. Available from: http://www.emcdda.europa.eu/stats11/hsrfig3
5. United Nations Office on Drugs and Crime (UNODC). HIV, HBV and HCV Behavioral Surveillance Survey among Injecting Drug Users in Bucharest, Romania. Bucharest: Speed Promotion; 2010.
6. Romanian National Antidrug Agency. National Report to the EMCDDA on the Drugs Situation in Romania, Bucharest. Bucharest: Romanian National Antidrug Agency; 2011.
7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Statistical Bulletin 2011. Figure HSR-1. Opioid substitution treatment clients as a percentage of the estimated number of problem opioid users, 2009 or most recent year available. Lisbon: EMCDDA; 2011. [Accessed 29 Nov 2011]. Available from: http://www.emcdda.europa.eu/stats11/hsrfig1
8. European Centre for Disease Prevention and Control (ECDC). Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report. Stockholm: ECDC; 2010. [Accessed 29 Nov 2011]. Available from: http://ecdc.europa.eu/en/publications/Publications/1009_SPR_Dublin_declaration_progress_report. pdf.
9. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2011 Annual report on the state of the drugs problem in Europe. Lisbon: EMCDDA; 2011. [Accessed 29 Nov 2011]. Available from: http://www.emcdda.europa.eu/publications/annual-report/2011
10. Kivelä P, Krol A, Simola S, Vaattovaara M, Tuomola P, Brummer- Korvenkontio H, et al. HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets. Eur J Public Health. 2007;17(4):381-6.
11. Skar H, Sylvan S, Hansson HB, Gustavsson O, Boman H, Albert J, et al. Multiple HIV-1 introductions into the Swedish intravenous drug user population. Infect Genet Evol. 2008;8(5):545-52.
12. Caplinskiene I, Caplinskas S, Griskevicius A. [Narcotic abuse and HIV infection in prisons]. Medicina (Kaunas). 2003;39(8):797-803. Lithuanian.
13. Wiessing L, Likatavicius G, Hedrich D, Guarita B, Van de Laar M, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48):pii=20031. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20031
14. Rhodes T, Hedrich D. Harm reduction and the mainstream. In: Rhodes T, Hedrich D, editors. Harm Reduction: Evidence, impacts and challenges. Lisbon: EMCDDA; 2010.
15. European Centre for Disease Prevention and Control (ECDC)/World Health Organization (WHO) Regional Office for Europe. HIV/AIDS Surveillance in Europe 2010. Stockholm: ECDC. 2011. [Accessed 29 Nov 2011]. Available from: http://ecdc.europa.eu/en/publications/Publications/111129_SUR_Annual_HIV_Report.pdf
16. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Joint ECDC and EMCDDA rapid risk assessment: HIV in Injecting Drug Users in the EU, following a reported increase of cases in Romania and Greece. ECDC/EMCDDA; 2011. Restricted-access document.
17. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour. Stockholm: ECDC/EMCDDA; 2011. [Accessed 29 Nov 2011]. Available from: http://ecdc.europa.eu/en/publications/Publications/111129_TER_ECDC-EMCDDA_report_part1.pdf
18. European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 2: Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour. Stockholm: ECDC/EMCDDA; 2011. [Accessed 29 Nov 2011]. Available from: http://ecdc.europa.eu/en/publications/ Publications/111129_TER_ECDC-EMCDDA_part2.pdf
19. Suhrcke M, Stuckler D, Suk JE, Desai M, Senek M, McKee M, et al. The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One. 2011;6(6):e20724.
20. Friedman SR, Rossi D, Braine N. Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks. Int J Drug Policy. 2009;20(3):283-91.
21. Kentikelenis A, Karanikolos M, Papanicolas I, Basu S, McKee M, Stuckler D. Health effects of financial crisis: omens of a Greek tragedy. Lancet. 2011;378(9801):1457-8.
22. Voelker R. One casualty of global economic crisis: uncertain finances for HIV/AIDS programs. JAMA. 2010;303(3):259-61.